GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Net Income From Continuing Operations

Intravenous Infusions (XGHA:IIL) Net Income From Continuing Operations : GHS0.00 Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Intravenous Infusions's net income from continuing operations for the six months ended in . 20 was GHS0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Net Income From Continuing Operations Historical Data

The historical data trend for Intravenous Infusions's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Net Income From Continuing Operations Chart

Intravenous Infusions Annual Data
Trend
Net Income From Continuing Operations

Intravenous Infusions Semi-Annual Data
Net Income From Continuing Operations

Intravenous Infusions Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:531015 BOM:524516 BOM:539680 BOM:531521 PTLF BOM:524590 BOM:524606 BOM:536565 PCYN BOM:532021 BOM:540359 TSXV:CIP.H BOM:531686 BOM:524314 BOM:511523 FRA:3SQ1 BOM:532167 BOM:524632 YBAO BKIT
Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Website
https://www.iil.com.gh
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.